Bayer extends collaborative oncology projects in Singapore
This article was originally published in Scrip
Executive Summary
In its largest single R&D investment in the island state to date, Bayer HealthCare has allocated S$14.5 million ($11.0 million) to a series of new collaborative oncology research partnerships with several organisations in Singapore.